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Abstract: Enterohemorrhagic E. coli (EHEC) strains constitute a subset of the verotoxigenic 
E. coli (VTEC) or Shiga toxin (Stx)-producing E. coli (STEC). Within this group, E. coli O157:H7 
is the most well-known Stx-producing serotype. EHEC strains produce hemorrhagic colitis 
and hemolytic uremic syndrome in humans. Like enteropathogenic E. coli (EPEC) strains, they 
mediate their pathogenesis through “attaching and effacing” (A/E) lesions. Cattle are the main 
reservoir of E. coli O157:H7 and they are directly linked to most of the human outbreaks. In 
this review, the virulence factors involved in the pathogenesis of EHEC strains, especially 
those participating in the colonization of the bovine intestinal mucosa, are analyzed. 
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E. coli ENTEROHEMORRáGICA: 
FACTORES DE VIRULENCIA E INFECCIÓN EN EL GANADO
Resumen: Las cepas de E. coli enterohemorrágica (EHEC) constituyen un subgrupo de las 
E. coli verotoxigénicas (VTEC) o E. coli productoras de toxinas Shiga (Stx) (STEC). Dentro de 
este grupo, E. coli O157:H7 es el serotipo productor de Stx más conocido. Las cepas de EHEC 
producen colitis hemorrágica y el síndrome urémico hemolítico en humanos. Al igual que las 
cepas enteropatogénicas de E. coli (EPEC), estas cepas median su patogénesis a través de 
lesiones de “adherencia y destrucción” (lesión A/E). El ganado bovino es el principal reser-
vorio de E. coli O157:H7 y se lo asocia directamente a la mayoría de los brotes en humanos. 
En esta revisión se analizan los factores de virulencia involucrados en la patogénesis de las 
cepas EHEC, especialmente aquellos que participan en la colonización de la mucosa intestinal 
de los bovinos. 
Palabras Clave: EHEC, E. coli O157:H7, factores de virulencia, ganado bovino, coloni-
zación
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INTRODUCTION
Escherichia coli belongs to the family En-
terobacteriaceae, which contains mostly motile, 
Gram-negative bacilli. E. coli strains that cause 
diarrhea are classified into six categories: EPEC 
(enteropathogenic E. coli); EHEC (enterohemor-
rhagic E. coli); ETEC (enterotoxigenic E. coli); 
EIEC (enteroinvasive E. coli); EAEC (enteroag-
gregative E. coli); and DAEC (diffusely adherent 
E. coli) (25). EPEC strains are an important cause 
of diarrhea in developing countries and, as part 
of their pathogenesis, they mediate the produc-
tion of “attaching and effacing” (A/E) lesions (25). 
ETEC strains elaborate enterotoxins, which are 
the main cause of intestinal secretion. EAEC 
strains do not secrete enterotoxins and they have 
the ability to attach to each other in aggregates or 
in a “stacked-brick” configuration on the surface 
of host cells in vitro. In contrast, DAEC strains 
produce a diffuse pattern of adherence. EIEC 
strains are closely related to Shigella spp. and 
they cause invasive inflammatory colitis, dys-
entery and watery diarrhea (25). Finally, EHEC 
strains are an important cause of hemorrhagic 
colitis (HC) and hemolytic uremic syndrome 
(HUS) in humans. Like EPEC strains, they also 
cause A/E lesions. EHEC strains constitute a 
subset of the verotoxigenic E. coli (VTEC) or Shiga 
toxin (Stx)-producing E. coli (STEC) because of 
their ability to produce toxins that are cytotoxic 
to Vero cells (immortalized monkey kidney cells) 
and because these toxins are variants of the Shiga 
toxin produced by Shigella dysenteriae serotype 
1. Not all STEC are pathogenic; however, based 
on the original definition, all EhEC are considered 
pathogenic (29). The incidence of EHEC infection 
in humans is low even when the prevalence of 
Stx-producing strains in cattle (the main reser-
voir) is high, which suggests that Stx production 
alone may not be sufficient for EhEC infection (8, 
27, 60). Therefore, the terms STEC or VTEC are 
used to characterize bacterial strains that express 
cytotoxin irrespective of their pathogenicity. Ad-
ditional factors, such as a pathogenicity island 
(PAI) called “The Locus of Enterocyte Effacement” 
(LEE) and the large pO157 plasmid (60) appears 
to be required for full virulence. Within the EHEC 
group, E. coli O157:H7 is the most well-known 
Stx-producing serotype (40). E. coli O157:H7 is 
responsible for two-thirds of the EHEC infections 
in the United States, with the other one-third of 
cases attributed to non-O157 STEC, mainly O26, 
O111, O103 and O145 serotypes (27, 57).
EHEC-ASSOCIATED HUMAN DIS-
EASE
E. coli O157:H7 is an emerging zoonotic 
pathogen that causes HC and HUS. In some 
cases, humans infected with EHEC strains may 
remain asymptomatic or exhibit mild, non-bloody 
diarrhea (40, 54). In other cases, HC may be the 
only manifestation of E. coli O157:H7 infection, 
or this condition can progress to HUS (54). HUS 
occurs most frequently in children younger than 
5 years old, after a bloody diarrheal prodrome (40, 
54). Elderly and immunocompromised individu-
als also have a high risk of developing clinical 
disease (42, 54).
HUS is characterized by non-immune 
hemolytic anemia, thrombocytopenia and acute 
renal failure (42). Complications involving the 
central nervous system (CNS) can also occur in 
30 %-50 % of patients. Thrombotic thrombo-
cytopenia purpura (TTP), which has only been 
reported in adults, was thought to represent a 
more extensive form of the clinical spectrum that 
causes HUS (54). However, TTP is now known to 
involve a process distinct from STEC-induced 
damage (56). There is no specific treatment for 
E. coli O157:H7 infections, other than supportive 
therapy and management of complications (54, 
56, 57).
PATHOGENESIS OF EHEC 
The infection dose of E. coli O157:H7 is 
low, and the production of Stx is the most impor-
tant virulence trait responsible for the local and 
systemic outcomes of infection. Local intestinal 
damage, which includes microvascular injury, 
results in bloody diarrhea, whereas HUS results 
from microvascular injury at extra-intestinal 
sites, especially in the kidney and brain (40, 56, 
60). It has been estimated that the infective dose 
to cause hUS is <50 organisms. Approximately 10 
organisms are able to cause disease in outbreaks 
associated with non-O157 STEC (27). The incuba-
tion period ranges from 1 to 9 days (54, 56, 60) 
and diarrhea usually lasts for 3 to 7.5 days (54, 
56). Clinical symptoms of EHEC infection include 
severe abdominal cramps, nausea and vomiting. 
Unlike other bacterial infections causing bloody 
diarrhea, fever is not always present or it can be 
very mild (54). 
EHEC produces two types of Stx, Stx1 
and Stx2. The risk of HUS is higher with E. coli 
O157:H7 isolates containing Stx2 genes, which 
suggests that this toxin is more virulent than 
Stx1 (54). There is no evidence of bacteremia 
in human disease (40). However, Stx produc-
tion triggers a cascade of coagulative events 
that results in widespread thrombus formation 
and systemic disease. It is believed that E. coli 
O157:H7 releases toxins in the bowel and after 
their absorption into the circulation, they induce 
vascular endothelial damage (54). The kidney 
and CNS have high levels of toxin receptor (40, 
60). Thus, these organs are particularly targeted 
during infection. Thrombotic microangiopathy 
is the main histopathological feature observed 
in patients with HUS. At the intestinal level, the 
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ly, sheep are also considered an important EHEC 
reservoir (8). It is estimated that 10% to 80% of 
cattle may carry Stx-producing E. coli (60) and 
because most ground beef is derived from adult 
cattle, it is critical to reduce E. coli O157:H7 in 
this population (12). In young calves (> 3 weeks 
old), experimental inoculation of E. coli O157:H7 
(1010 CFU) does not induce significant clinical 
disease (13) and the presence of A/E lesions is not 
readily detected, suggesting that E. coli O157:H7 
localizes within the intestinal content rather than 
in the mucosal surface (7).
E. coli O157:H7 fecal shedding in healthy 
cattle is usually transient or intermittent (26, 27) 
and the prevalence is highly variable. Smith et 
al. (49) determined that the prevalence by pen in 
feedlot cattle varied from 1 % to 80 %. In other 
studies, prevalences of 13.4 % in beef cattle and 
16.1 % for cull dairy cattle were reported (42). Fe-
gan et al. (15) reported no significant differences 
in prevalence in grain- (15 %) or grass- (10 %) 
fed cattle. High isolation rates of E. coli O157 in 
mouth and hide samples have been reported, 
indicating that cattle may have additional sites of 
bacterial colonization or carriages other than the 
distal gastrointestinal tract (52). The prevalence 
of E. coli O157:H7 in fecal samples is highest 
in summer and lowest during winter (27). It is 
also known that a high percentage of cattle shed 
the bacterium for a short period of time, which 
is followed by longer periods of low prevalence 
within herds (42). The magnitude and duration 
of fecal shedding of E. coli O157:H7 is usually 
greater in calves than in adults. It is believed 
that age-related differences in rumen function 
(concentration of volatile fatty acids [VFA], pH) 
may contribute to this phenomenon (12). Gastro-
intestinal disturbances and feeding regimens can 
also affect the pattern of fecal shedding (42). It 
has also been established that previous infection 
does not prevent re-infection against a high-level 
challenge of E. coli O157:H7 (7, 12). 
E. coli O157:H7 can be horizontally trans-
mitted among cattle (42). Bretschneider et al. (5) 
showed that experimentally infected adult beef 
cattle shed E. coli O157:H7 for 24 days (range of 
8-42 days). Similarly, Besser et al. (1) reported 
that the duration of fecal excretion of E. coli 
O157:h7 in naturally infected cattle was < 1 
month. Kahitsa et al. (26) found that the length 
of fecal shedding in feedlot cattle ranged from 1 
to 4.5 weeks, and peaked during the epidemic 
phase, which corresponds to times of higher 
challenge levels. In contrast to the findings by 
Fegan et al. (16), in a sheep model, Kudva et al. 
(28) demonstrated that a dietary change from 
alfalfa pellet to grass, by itself or in combination 
with withholding of feed for 24 hours, triggered 
the excretion of E. coli O157:H7 in experimental 
infected lambs. It was hypothesized that the 
most severe abnormalities occur in the cecum 
and ascending colon. In cases of HC, colonic 
mucosal edema, erosion and hemorrhages are 
evident (54). 
TRANSMISSION AND EPIDEMIOLOGY
E. coli O157 is a widespread zoonotic, 
food-borne pathogen, with water-borne, animal-
to-person and person-to-person transmission 
implicated in human outbreaks (42, 59). Infected 
cattle are the main reservoir of EHEC O157 and 
other strains (54, 59). Animals colonized by 
EhEC are difficult to identify since infection of 
calves, adult cattle and sheep is asymptomatic 
(53). STEC strains can remain viable in feces 
for months (8). The presence of E. coli O157 in 
cattle feces represents a serious public health 
risk due to direct bacterial transmission to people 
or fecal contamination of food, water and/or the 
environment (42). Feces of non-bovine species 
such as sheep, dogs, horses, flies and birds can 
also contain E. coli O157. Vegetables, fruits and 
inadequately pasteurized milk are other vehicles 
of infection (59, 60). 
Many recent outbreaks of E. coli O157:H7 
infection have been associated with low pH prod-
ucts (salami, yogurt), highlighting the ability of 
the bacterium to tolerate acidic pH and survive 
processes of fermentation and drying (8). Trans-
mission of E. coli O157:H7 to humans has been 
primarily linked to undercooked meat since under 
these conditions, the bacteria survive and retain 
pathogenicity. Food can be cross-contaminated 
by improper handling procedures during manu-
facturing, storage, marketing and even in the 
household itself (59). 
E. coli O157:H7 infection of humans has a 
peak incidence during warmer months (54). The 
first outbreaks associated with E. coli O157:H7 
infection were registered in 1982, in Michigan 
and Oregon. In both cases EHEC was transmit-
ted by undercooked beef (60). In Europe, serotype 
O157:H-(non-motile), sorbitol-fermenting STEC 
strains have emerged as a cause of HUS. In South 
America, E. coli O157:H7 infections are endemic, 
with Argentina being the country with the highest 
incidence (more than 300 cases each year) (11).
The case-fatality rate of HUS ranges be-
tween 0 % and 30 % and the risk of developing 
hUS after EhEC infection is 2 % to 7 % (59). 
About 30 % of hUS patients suffer permanent 
disabilities, including chronic renal insufficiency, 
hypertension and neurological disorders (60).
CATTLE AS E. coli O157:H7 RESER-
VOIR
Cattle are considered the main reservoir of 
E. coli O157:H7 strains (8, 42) and they can also 
harbor non-O157 STEC serogroups (27). Present-
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dietary shift induced a selective E. coli O157:H7 
growth in the intestine. They suggested that feed 
withholding might induce bacterial shedding 
in animals by triggering the growth of E. coli 
O157:H7 present in the intestine or by increas-
ing the susceptibility to infection. Furthermore, 
fasting also causes an increase in rumen pH and 
a drop in VFA concentration, which favor E. coli 
O157:H7 proliferation (53).
VIRULENCE FACTORS
lOCuS OF ENTEROCYTE EFFACEMENT 
(lEE) 
PAIs are large regions of chromosomal DNA 
(10-200 kilobases) that are essential for bacte-
rial pathogenicity. PAIs are usually associated 
with tRNAs, they have different G+C content and 
codon usage from the rest of the genome and 
their borders are marked by repeated sequences 
or insertion elements (25, 31). The ability to 
induce A/E lesions is encoded by genes on a 
35-kilobase PAI called “The Locus of Enterocyte 
Effacement” (LEE) (25, 35). LEE 1, 2 and 3 are 
identical in EHEC and EPEC and they encode 
products required for type III secretion. LEE 4 
encodes the E. coli secreted proteins EspA, EspB, 
EspD and EspF. A further operon contains Tir, 
its chaperone CesT, and intimin (45). In EHEC, 
LEE enables bacterial colonization of the intes-
tinal tract (43). 
The Ler locus in EHEC and EPEC encodes 
a regulator of virulence gene expression, which 
directly modulates genes within the LEE elements 
in response to environmental signals inside the 
human gut (21). Therefore, Ler is essential for 
the formation of A/E lesion. 
Quorum sensing (QS) is a mechanism by 
which bacteria regulate their gene expression 
in response to cell density, via the production 
of hormone-like compounds (auto-inducers), 
which stimulate gene expression (10). QS has 
been shown to be involved in the regulation of 
the expression of EPEC and EHEC LEE operons 
by Ler. However, because of the low infectious 
dose of EHEC, these strains should detect auto-
inducer signals produced by commensal E. coli 
and other bacteria present at high concentration 
in the large intestine to initiate the expression of 
virulence factors (25, 40).
 
THE TYPE III SECRETION SYSTEM 
(TTSS)
Four pathways of protein secretion have 
been described in Gram-negative bacteria (types I 
to IV). A fifth system, involved in conjugal transfer 
of plasmids, is not well-characterized (15, 18, 23). 
For some Gram- negative pathogens, the TTSS is 
an essential virulence determinant (23) required 
for the delivery of bacterial factors into the host 
cells (9, 18, 31). The best-studied TTSS is that 
of Yersinia spp. In EHEC, the TTSS is primarily 
required for the persistence of the bacterium in 
the terminal portion of the gastrointestinal tract 
(45).
Most of the bacterial pathogenicity factors 
interact with eukaryotic host cells (23). Therefore, 
virulence factors are exposed either at the surface 
of the bacterial cell or are transported out of the 
bacteria. The outer membrane in Gram-negative 
microorganisms led to the evolution of secretion 
systems which are different from those of Gram-
positive bacteria. In EPEC and EHEC, the TTSS is 
dedicated to the secretion of specific proteins (Tir, 
EspA, EspB and EspD), which are essential for 
the subversion of signal transduction pathways 
and the formation of A/E lesions (9). The TTSS 
functions by a “contact-mediated” mechanism, 
i.e it is triggered when a pathogen comes in close 
contact with a host cell (18, 31). The TTSS is 
composed of about 20 proteins, most of which 
are located in the inner membrane (15, 18, 23), 
and are homologous to the flagellar biosynthesis 
apparatus (18, 23, 31). 
Secreted proteins require small cytoplasmic 
proteins (chaperones), to prevent premature in-
teraction with other components of the secretion 
system (23, 31). Chaperones physically associ-
ate with the effector in the bacterial cytosol and 
remain at this location following translocation 
of the effector into the host cell. Then, bacte-
rial proteins are released through a prominent 
needle-like structure on the outer surface of the 
bacterial cell (18). 
When A/E pathogens enter their host via 
ingestion, the gastrointestinal conditions activate 
LEE gene expression, leading to the assembly of 
the TTSS apparatus. A/E pathogens use calcium 
concentrations to regulate type III secretion and 
to control the hierarchy of translocators (EspA, 
EspB and EspD) and effectors (EspF, EspG, 
EspH, Tir and Map). The levels of calcium present 
in the extracellular fluid of the intestinal lumen 
trigger the secretion of EspA, EspB and EspD, 
which mediate the assembly of the translocon and 
the formation of a pore in the host cell membrane. 
In the bridge that connects the bacterial and host 
cytoplasm, the calcium concentration is limited. 
Therefore, low levels of calcium suppress the se-
cretion of translocators and activate the secretion 
of effectors. Other environmental signals might 
also play a role in regulating TTSS (14).
E. coli -SECRETED PROTEINS (ESP)
At least eight Esp have been identified, of 
which six are encoded by the LEE. Particularly, 
EspA, EspB and EspD are proteins secreted in 
significant quantities in a TTSS-dependent man-
ner by EPEC strains. These proteins are required 
for effector proteins secretion and A/E lesion 
formation (10). 
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EspA is a 20-kDa protein (198 amino-
acids) (18, 23) which forms filaments that bridge 
the bacteria and the host cell membrane (46) to 
carry proteins from the pathogenic bacteria to 
the host cell (18). EspA filaments are usually 90 
nm in length (18) and are found on the bacterial 
surface at early stages of A/E lesion formation 
(9). EspA might also act as a bacterial adhesin 
at the initial stages of infection (9, 15). EspA fila-
ments are required for the delivery of EspB. EspA 
initiates polymerization from the tip of the needle 
and assembles a sheath-like structure, which is 
expandable and its elongation is controlled by the 
amount of EspA (46). EspA amino and carboxyl 
termini are conserved between EPEC and EHEC. 
However, the central region of the protein is vari-
able and may influence the cell-binding specificity 
of the different strains (51).
The espB gene product is a 37-kDa protein 
(321 amino acids), which is an essential signal 
transduction molecule (23). EspB is translocated 
and it is required for the translocation of other 
proteins (15). EspB becomes resistant to protease 
digestion upon association with the host cell. It 
is required for tyrosine phosphorylation of Tir in 
EPEC and for the accumulation of actin filaments 
beneath adherent bacteria (23). EspB binds EspA, 
which suggests that there is a continuous path 
between the filament and the host cell. Together 
with EspD, EspB forms a pore in the distal part 
of the EspA filament (18, 45) which is required 
to insert Tir into the eukaryotic membrane (23). 
EspA and EspB are critical for disease and are 
involved in inflammation and disruption of the 
mucosal epithelial surface. They are critical for 
A/E lesion formation, cytoskeletal rearrange-
ment and formation of cup-like structures in 
vivo (15).
EspD is a 39-kDa protein (381 amino ac-
ids) (10, 23). It is involved in the formation of the 
translocon; thus, its primary function would be 
the delivery of other virulence factors rather than 
acting as an effector (9). 
EspF is a 21-kDa, proline-rich, effector 
protein translocated by the TTSS (9, 10) but not 
required for A/E lesion formation (10). It is in-
volved in EPEC-induced host cell death (45) and 
disruption of the host intestinal tight-junctions 
through the re-distribution of occludin, a com-
ponent of the cellular tight-junctions (9, 25). 
EspF also appears to promote EHEC colonization 
by modulating the host inflammatory response 
through inhibition of polymorphonuclear cells 
accumulation in the colon (43).
Little is known about EspG function. It is a 
44 kDa-protein, which appears to be involved in 
virulence, but which does not seem to function 
in A/E lesion development (10). However, EspG 
deletion mutants have reduced levels of intestinal 
colonization. This protein would cause transient 
microtubule destruction and actin polymeriza-
tion (51).
The functions of EspH have not been 
completely studied. It is a modulator of the host 
actin cytoskeleton with the effect of repressing 
the formation of filopodia and enhancing the 
formation of actin pedestals (58). EspH also 
promotes EHEC-induced diarrhea and intestinal 




Map is a multifunctional protein that 
induces the formation of filopodia via the Rho 
GTPase Cdc42 and also targets the mitochondria 
to disrupt their membrane potential (25). Map-
induced signaling inhibits pedestal formation. In 
contrast, Tir, in association with intimin, down-
regulates filopodia formation by Map (45), prob-
ably as a required step for A/E lesion formation 
(10). In a yeast model, EPEC Map, together with 
EspD and EspG, was demonstrated to inhibit 
growth by depolarization of the actin cytoskel-
eton (44). 
In conclusion, EspH, EspF, EspG and Map 
are not required for A/E lesion formation in vitro 
or in vivo. However, they appear to be important to 
guarantee maximal intestinal colonization (43).
TRANSlOCATEd-INTIMIN RECEPTOR 
(TIR)
Tir is a 72-kDa protein (549 amino acids), 
which is secreted by the TTSS into the eukaryotic 
membrane (23). Tir is the first recognized example 
of a bacterium inserting its own receptor into the 
host cell membrane (9). It contains two potential 
transmembrane domains (15, 17, 23), and func-
tions as a receptor for the bacterial attachment 
factor, intimin (16, 23, 25). Tir anchors intimin 
to the host cell actin and other cytoskeleton 
proteins. Thus, the bacteria can initiate pedes-
tal formation and mediate its pathogenic effect 
while remaining on the extracellular surface 
(9). Tir promoter activity is almost undetectable 
before bacteria-host cell contact. However, it is 
expressed at higher levels after host cell contact 
has taken place (45).
Tir and its chaperone, CesT (16, 45), are 
encoded by LEE, immediately upstream of the 
eae intimin gene (16). In EPEC, CesT is criti-
cal for Tir secretion by the recruitment of Tir 
to the inner membrane (45). The affinity of Tir 
for intimin is higher in its free state than in its 
chaperone-bound form (CesT-Tir). In addition to 
binding Tir, E. coli - CesT binds Map (18), having 
a central role in its secretion. 
Once transferred into eukaryotic cells, Tir 
is phosphorylated on C-terminal tyrosines and 
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this phosphorylation appears to be required for 
the function of Tir as an actin nucleator (23, 
25, 45) and as a signal transduction molecule 
in epithelial cells. Tir orchestrates pedestal for-
mation and directs the recruitment of several 
cytoskeletal proteins to the site of EHEC attach-
ment. In contrast to EPEC, in EHEC, cytoskeletal 
protein recruitment is independent of the tyrosine 
phosphorylation by Tir (45). Furthermore, the 
Tir protein of EHEC O157:H7 is not functionally 
identical to that of EPEC because EHEC pedestal 
formation is initiated without Tir binding to the 
adaptor protein Nck (25), which is implicated 
in the initiation of actin signaling (10). Thus, in 
EHEC, additional bacterial factors are translo-
cated to trigger actin signaling (25).
Recently, studies demonstrated that Tir is 
essential for E. coli O157:H7 intestinal coloniza-
tion in calves (47), mainly because it mediates 
bacterial attachment to the intestinal mucosa 
via intimin binding.
INTIMIN
Intimin is a 94-kDa outer membrane pro-
tein (23), which resembles eukaryotic adhesion 
molecules (16). It is not secreted by the TTSS, 
but it is encoded within the same gene cluster 
that encodes this bacterial system (23). The eae 
gene is present in EPEC and EHEC and there 
is an 86% sequence homology (60). Expression 
of intimin is essential for A/E lesion formation 
and is required for full virulence (15, 23, 47). 
Intimin binding to Tir elicits cytoskeletal rear-
rangements within the host cell, leading to the 
formation of actin-rich pedestals beneath the 
adherent bacteria (15). Intimin also binds host-
encoded receptors, such as β1 integrin (35). A 
role for intimin in the stimulation of mucosal 
Th1 responses and intestinal crypt hyperplasia 
has also been reported (25). At an early stage 
of A/E lesion formation, intimin would have an 
additional, Tir-independent function, involving 
the remodeling of the mammalian cell surface 
(9, 17). 
At least 17 types of intimin (α, β, γ, δ, ε 
and others) have been identified, according to 
amino-acid variations at the C-terminal domain. 
Intimin α is found in EPEC strains, whereas 
intimin γ is specifically associated with EhEC 
O157:H7. The existence of different intimin types 
suggests that the protein is responsible for the 
differential tissue targeting exhibited by EHEC 
and EPEC (8, 9, 17). Despite the importance of 
intimin in intestinal colonization of cattle, the 
eae gene is not present in all Stx-producing E. 
coli strains isolated from cattle, suggesting that 
other factors may influence the persistence of 
the bacteria in the bovine gastrointestinal tract 
(53).
ATTACHINg ANd EFFACINg (A/E) lE-
SION
EPEC is a well-studied pathogen that causes 
A/E lesions in intestinal cells. Other pathogens 
include Hafnia alvei, Citrobacter rodentium and 
EHEC (35). A/E bacteria can affect the small or 
the large intestine, and they cause diarrhea (60), 
likely because of a reduction in the absorptive 
capacity of the intestinal mucosa and the conse-
quent electrolyte imbalance (10). Whereas EPEC 
strains colonize both the small and large bowel, 
EHEC strains are only localized in the large in-
testine (33). The mucosa of the terminal rectum 
(3-5 cm proximal to the recto-anal junction) is the 
principal site of colonization of EHEC O157:H7 
(32). After initial adherence, EPEC strains attach 
intimately to the epithelial cell surface, leading 
to the effacement of the microvilli beneath the 
bacteria. This characteristic clustered pattern of 
adherence produces the histopathologic pheno-
type known as the A/E lesion. Both intimin and 
EPEC TTSS are required for intimate attachment 
(23) and lesion formation.
Subjacent to adherent bacteria, the host 
cellular cytoskeleton is re-organized into a le-
sion in which the surface microvilli are disrupted 
and F-actin is recruited into a pedestal structure 
(15). As long as the host cell remains healthy, the 
bacteria remain attached and multiply on the 
surface of the cell (45). 
EspA filaments are excluded from the re-
gion of intimate contact once A/E lesions are 
produced. Therefore, fully developed A/E lesions 
are devoid of EspA filaments (15). 
A three-stage model was described for the 
interaction of EPEC with epithelial cells and A/E 
lesion formation: (1) localized adherence (initial, 
non-intimate attachement); (2) signal trans-
duction; and (3) intimate adherence. In EPEC, 
localized adherence is mediated by the plasmid-
encoded bundle forming pili (BFP) (9, 35). Al-
though initial adherence is not essential for A/E 
lesion development (9, 35), BFP helps to bring 
the bacteria in close contact with the host cells 
(35). In contrast to EPEC, EHEC does not carry 
BFP (60, 51). In association with the constant 
peristaltic flushing that this microorganism must 
surmount, the specific tropism of E. coli O157:H7 
for the terminal rectum (32) would indicate that 
an initial adherence factor is needed to facilitate 
the final colonization by a highly complex A/E 
mechanism. In this regard, it was recently es-
tablished that h7 flagella act as an adhesin to 
the bovine intestine in the crucial initiating step 
of E. coli O157:H7 colonization (30). During the 
intimate adherence, EspA filaments are lost from 
the bacterial cell surface (10) and intimin/Tir 
binding activates additional signaling cascades 
that induce cytoskeletal rearrangements to form 
the pedestals upon which A/E bacteria reside 
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(9, 15, 35). Actin is the major component of the 
brush border cytoskeleton and the site-specific 
concentration of cytoskeletal actin is characteris-
tic of A/E histopathology. Actin pedestals are up 
to 10 um in length (9). Other cytoskeletal proteins 
(α-actinin, talin, erzin, villin, myosin light chain, 
VASP, WASP and arp2/3 complex) are also pres-
ent in A/E lesions, and they accumulate under 
the adherent bacteria within 3 hours of EPEC in-
fection (9). An elevation in the intracellular levels 
of calcium can contribute to the depolymerization 
of actin and, consequently, to the breakdown of 
host cytoskeleton during A/E lesion formation. 
Interestingly, EPEC does not have an effect on the 
Rho family of small GTP-binding proteins that are 
normally involved in cytoskeletal rearrangement. 
Therefore, EPEC would use a non-traditional 
mechanism for actin rearrangement. 
SHIgA TOXIN (STX) FAMIlY
The toxin known as “Shiga toxin” is the 
exotoxin of Shigella dysenteriae type I. The terms 
Shiga toxin and Verotoxin are synonymous. Vero 
cells are killed within a few hours by low doses 
of Stx (57). Stx is considered the key virulence 
factor of EHEC (54). As previously mentioned, 
the Stx family contains two subgroups, Stx1 and 
Stx2, which share approximately 55% amino-acid 
homology (25, 40). Stx1 shows little sequence 
variation; however, several variants of Stx2 have 
been described (8). 
Most Stxs are encoded by lambda-like bac-
teriophages (25, 54), and they are transcribed 
from a promoter that also controls the expression 
of late lambda phage lysis genes, thereby linking 
toxin expression with a lytic function responsible 
for the release of the toxin (25).
All Stxs consist of an A subunit (toxic 
moiety) and five B subunits (receptor binding) 
(57, 59). Stx1 differs by only one amino acid on 
subunit A with respect to Stx2 and they share the 
same cell receptor and intracellular mechanism 
of action in vitro (54). 
To enter into de cell, the B chains bind to 
the Gb3 receptor, also known as CD77 or PK 
(57). Once the holotoxin is internalized into an 
endosome, the A subunit is cleaved. The free A 
chain has N-glycosidase activity (57, 59); adenine 
is cleaved from the ribosomal RNA at a point 
where the aminoacyl transfer RNA is assembled, 
thus, arresting protein synthesis (51, 57). Stx 
can also induce direct apoptosis of renal (59) and 
epithelial cells (25) and it can trigger monocytes 
to produce and release cytokines such as TNF-α, 
IL1-β, IL-6 and IL-8 (40), likely using a receptor 
different from Gb3 (57). In addition, Stx is also 
able to bind to platelets and trigger their direct 
activation (40).
Stx2 increases the severity and duration 
of EHEC-induced diarrhea and modulates the 
host inflammatory response in the infant rabbit 
model. Gut inflammation would facilitate the 
severe manifestations of EHEC infection by al-
lowing increased uptake of Stx from the lumen 
into the systemic circulation (60). In cattle, Stx 
down-modulates the mucosal inflammatory re-
sponses (51).
Stx1 is more frequently identified in cattle 
isolates, whereas Stx2 is more prevalent in hu-
man isolates (27, 57) and it has been suggested 
that Stx2 is more virulent in humans than Stx1 
(40). It is believed that the distribution of the Gb3 
receptor is responsible for the devastating effects 
of human infections by EHEC and for the absence 
of clinical symptoms in cattle. Unlike humans, 
Gb3 is not present on bovine endothelial cells. 
Therefore, Stx expression does not produce the 
severe vascular injury and hemorrhage observed 
in humans (51). The production of Stx distin-
guishes EHEC from EPEC. STEC serotypes do 
not normally invade the host, but the immediate 
proximity of colonizing bacteria to the epithelium 
might promote the delivery of Stx directly to the 
mucosa (25, 57). 
pO157 PLASMID 
The pO157 plasmid of EHEC encodes 35 
proteins (8), some of which are accessory toxins 
(25). This 90-Kb plasmid (8, 60) is present in 
almost all EHEC isolates that encode an EHEC 
hemolysin (60). The pO157 plasmid also encodes 
an EHEC KatP catalase-peroxidase and an ex-
tracellular serine-protease, EspP. This protease 
cleaves pepsin A and human coagulation factor 
V, suggesting that it may participate in the in-
duction of intestinal hemorrhage (8, 60). Another 
virulence gene, toxB, which appears to be present 
in all EHEC O157 isolates, is also encoded within 
this plasmid. toxB may influence the expression 
of LEE-encoded type III secreted proteins and 
it may inhibit lymphocyte activation (8). Intra-
rectal inoculation of 5 to 8-month-old cattle with 
isogenic strains of E. coli O157:h7 identified a 
significant role for the pO157 plasmid in the 
colonization of the terminal rectum (47).
EHEC HEMOlYSIN
ehxA is the structural gene for the entero-
hemolysin of EHEC, which is a pore-forming toxin 
(55). It might contribute to EHEC pathogenesis 
because the hemoglobin released during hemo-
lysis provides a source of iron to the bacteria. 
This would be especially important for human 
isolates but not for isolates from cattle. Together 
with intimin and Stx genes, the enterohemolysin 
appears to be a marker of virulence for most of 
the EHEC O157 and non-O157 strains (60).
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lIPOPOlYSACCHARIdE (lPS)
LPS is an endotoxin that consist of a lipid 
A, responsible for the toxic action; an O-antigenic 
polysaccharide (O-PL), which is structurally non-
conserved among related bacterial species; and 
a core oligosaccharide that links O-PL with lipid 
A (98). Endotoxemia is observed in patients with 
HUS caused by Shigella dysenteriae type I, but 
not in EHEC infection (56). However, it has been 
suggested a synergistic effect of Stx and LPS in 
the pathogenesis (40).
E. coli LPS has five distinct core oligosac-
charides structures, designated K-12 and R1 to 
R4. R3 is frequently found in STEC isolates from 
cattle and humans (18). Compared to healthy 
volunteers, serum from convalescent patients 
has significantly higher levels of IgA against O157 
LPS and R3. Because of its conserved structure, 
the core oligosaccharide is responsible for cross-
reactive antibodies. The R3 core LPS is the most 
common core type in the STEC group (19).
In calves and adult cattle, the serum anti-
body response to STEC O157 LPS lasts more than 
5 months (24). However, this immune response 
is unable to prevent re-infection with the homo-
logous STEC strain. 
FIMBRIAE
Fimbriae are thread-like structures that 
extend out from the bacterial surface and pro-
vide multiple functions, including adherence to 
host cells. Although EHEC contains 10 putative 
fimbrial loci, little is known about their relative 
contribution to virulence (53). Stx-producing 
E. coli do not produce type I fimbriae, the most 
common E. coli adhesin. Absence of fimbriae ex-
pression in EHEC O157 is due to the presence 
of a 16 base pair deletion within the regulatory 
region of fimA (60). 
NON FIMBRIAl AdHESINS
Adhesins are responsible for pathogen 
binding to intestinal epithelial cells (40). In addi-
tion to intimin, other adhesins would support the 
EHEC carrier state in the bovine intestine. LEE-
negative EHEC isolates from ruminants encode 
an auto-agglutinating adhesin (8, 53) and a novel 
type IV pilus (51). In non-O157 EHEC strains, a 
gene known as efa1, which encodes a factor of 
adherence has been identified (51, 53). 
E. coli are peritrichous flagellated bacteria 
that assemble about ten flagella over their cell 
surface (36).The flagellum consists of three mor-
phologically distinct structures: a basal body, a 
hook and a helical filament (2, 41, 94). The basal 
body is embedded in the bacterial cell envelope, 
whereas the hook and the filament extend beyond 
the cell surface (94). Flagella provide motility and 
chemotaxis (41), increase adhesion (20, 41) and 
are involved in protein translocation (20). Motil-
ity is considered a virulence factor that promotes 
establishment of infection and transmission 
(36). Flagellin, the structural component of the 
flagellar filament, also plays a major role in the 
induction of the host immune responses. Flagel-
lar expression is subject to phase variation and 
some pathogenic bacteria produce flagellin in 
order to promote colonization and mucosa inva-
sion (41). In EPEC strains, flagellin and BFP are 
produced simultaneously during infection. Like 
BFP, the flagellum is also directly involved in 
local adherence, contributing to A/E lesion for-
mation (20). Because EPEC flagella are involved 
in adherence and microcolony formation, it is 
required a coordinated transcription of the flagel-
lar system and the virulence genes encoded by 
the LEE, which are the main responsible for the 
development of A/E lesion (48). In addition to the 
TTSS, bacteria can use the flagellar system as an 
additional mechanism for the export of virulence 
factors (41). 
EhEC h7 flagella are composed of flagel-
lin subunits of about 66,000 Da and they have 
also been demonstrated to be immunogenic 
(30). Flagellin of EPEC is an important adhesive 
structure, which is highly induced upon inter-
action between epithelial cells and, probably, a 
secreted signaling molecule of eukaryotic origin 
(20). The authors could not demonstrate that 
EHEC H7 was able to mediate attachment to 
epithelial HeLa cells. However, Bretschneider et 
al. (4) demonstrated that E. coli O157:H7 strains 
lacking flagellin expression did not effectively 
colonize the intestine of adult beef cattle. In ad-
dition, animals inoculated with a non-flagellated 
variant of E. coli O157: H7 were more susceptible 
to a second challenge with a motile E. coli O157: 
H7 than those originally inoculated with motile 
strains. These findings suggested that this ap-
pendage has an essential function in colonization. 
Later, Mahajan et al. (30) confirmed the presence 
of abundant h7 flagella in physical contact with 
the terminal rectum epithelial cells, demonstrat-
ing that h7 flagellum acts as an adhesin, which 
is crucial in the initial step of colonization of E. 
coli O157:H7.
Hayashi et al. (22) demonstrated that flagel-
lin is the ligand for toll like receptor (TLR)-5. TLR-
5 is able to detect both extracellular-luminal and 
invasive-flagellated pathogenic bacteria (41). Rec-
ognition of flagellin by TLR-5 induces the expres-
sion of the pro-inflammatory cytokine IL-8, the 
recruitment of neutrophils to the site of infection, 
and the activation of dendritic cells (41). Flagellin 
is a potent stimulator of humoral immune mecha-
nisms, a hallmark of Th2 responses. Moreover, 
stimulation of an antibody response has been 
proposed to be related to the direct activation of 
dendritic cells within the mucosa by flagellin (41). 
Similar to EPEC, flagella from E. coli O157:H7 
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also induced IL-8 secretion in a colonic epithelial 
cell line (36). It was confirmed that h7 flagellin 
proteins, and not the production of Shiga-like 
toxins, are responsible for the up-regulation of 
pro-inflammatory chemokine production and 
sub-epithelial influx of neutrophils (7).
Microcolony formation and adhesion by 
EPEC depend on the coordinated transcription 
of flagellum and LEE genes (48). In addition, 
Girón et al. (20) demonstrated that EPEC strains 
that are mutated in the LEE-encoded genes are 
impaired in the expression of flagella. This was 
interpreted by the authors as indication of an 
association between flagellation, motility and the 
TTSS. Furthermore, Bretschneider et al. (2) found 
that E. coli O157:H7 tir deletion mutans were un-
able to express flagella and suggested a regula-
tory link between flagellum and Tir expression. 
Finally, Spears et al. (51) suggested that because 
of the importance of LEE-TTSS in the colonization 
process and the structural relationship between 
LEE and flagellar-TTSS, EhEC intestinal colo-
nization is likely to be mediated by a regulatory 
cross-talk between both systems.
CONTROL OF EHEC INFECTION IN 
CATTLE
Vaccines should induce high titers of spe-
cific IgA at mucosal surfaces to prevent cattle 
infection and shedding of EHEC into the environ-
ment and/or colostral IgG responses for passive 
protection of neonates (53). During the course 
of infection, adult cattle are able to mount a se-
rological response against E. coli O157:H7-type 
III-secreted proteins, intimin and LPS (5). Overall, 
these authors detected a positive association 
between the pattern of fecal shedding and the 
serum IgG titers to Tir, intimin or O157 LPS. 
However, for EspB, the IgG response was robust 
and persistent throughout infection, irrespective 
of the level of E. coli O157:H7 shedding. A positive 
relationship between hydrophilicity and immu-
nogenicity was previously shown by Noya et al. 
(34). In this regard, bioinformatics analysis of E. 
coli O157:H7 LEE proteins, revealed the presence 
of two main hydrophilic domains in the central 
and carboxy-terminal regions of EspB (3). An 
occasional and very low mucosal IgG and IgA re-
sponses were also detected on mucosal scrapings 
of terminal colon and rectum of experimentally 
infected adult cattle. However, it is unclear the 
role of these antibodies in the protection to the 
infection (6). 
Intimin would be a good candidate for 
vaccination. Nevertheless, these vaccines would 
require the incorporation of several intimin sub-
types, mainly β, γ, and ε, to protect against the 
prevalent EHEC serotypes in cattle (53).
A glycoconjugate vaccine containing O157 
LPS did not protect against intestinal coloniza-
tion of mice with E. coli O157:H7 (27). Although 
specific O antibodies are detected in the serum 
of experimentally infected calves, correlation with 
bacterial clearance is not observed (24). 
Potter et al. (39) demonstrated that a vac-
cine composed of E. coli O157:H7 culture super-
natant enriched with type III-secreted proteins 
was effective in reducing intestinal colonization of 
cattle. Peterson et al. (38) determined that a three-
dose regimen of this vaccine elicited a significant 
humoral response to Tir and LPS and reduced 
E. coli O157:H7 colonization of the terminal rec-
tum under natural exposure. Recently, Smith et 
al. (50) concluded that a two-dose regime of the 
same vaccine was also effective in reducing the 
probability (92%) of E. coli O157:H7 colonization 
of the terminal rectum of commercially fed cattle 
at harvest. Type III-secreted proteins are relatively 
conserved among EHEC serotypes. Therefore, it 
was proposed that this formulation would have 
the advantage of providing cross-protective im-
munity (39). However, preliminary results of a 
recent study by the same research group suggest 
that protection, for the most part, is serotype-
specific (3). 
The use of h7 flagellin, as a component of a 
systemic vaccine, reduced the colonization rates 
and delayed peak of O157:H7 shedding in calves; 
however, it did not affect total bacterial shedding. 
This immunization effect was correlated with 
serum and mucosal antibody responses (31). 
Immunological strategies, targeting h7 flagella, 
are actually under study (30).
Passive protection by the use of recombi-
nant antibodies directed to EHEC colonization 
factors in food-producing farm animals has also 
been proposed as a measure to reduce EHEC 
intestinal carriage before slaughter (53). 
Furthermore, probiotic mixtures have also 
shown some effectiveness in reducing intestinal 
colonization of experimentally inoculated young 
calves and sheep. A two-year clinical trial in 
a research feedlot with a direct- fed microbial 
showed that cattle were 35% less likely to shed 
E. coli O157:H7 than untreated cattle (37). The 
use of lytic bacteriophages and bacteria capable 
of inhibiting EHEC growth in the gastrointestinal 
tract might also be useful for the control of EHEC 
in ruminants prior to slaughter, although the de-
velopment of genetic resistance poses a problem 
to the long-term use of these control measure-
ments (53). The USDA Food Safety and Inspection 
Service has recently approved the use of bacterio-
phage treatment for E. coli O157:H7 in live cattle. 
Bacteriophages are applied as a mist, spray or 
wash on live animals prior to slaughter.
 Finally, it is important to consider that 
preharvest intervention strategies, for instance, 
vaccines against E. coli O157:H7 in cattle, must be 
produced at low cost to be adopted by farmers.
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